Parenteral Drug Association (PDA) is the recognised authoritative voice and leading technical organisation in the field of parenteral science and technology. Through the development of technical reports and responses to regulatory initiatives, PDA and its members influence the future course of pharmaceutical technology. With more than 9,500 individual members worldwide, the organisation draws its strength from the technical expertise of its membership. It is now concentrating on making its presence felt in India. In a tête-à-tête with PROCESS India, Richard M. Johnson, President, PDA, talks about the organisation’s offerings and future plans with regard to India.